Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Signal transduction in ischemic preconditioning

J M Downey1, M V Cohen

  • 1Department of Physiology, University of South Alabama College of Medicine, Mobile 36688, USA.

Zeitschrift Fur Kardiologie
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection.

Basic research in cardiology·2016
Same author

Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood.

Cardiovascular drugs and therapy·2015
Same author

Pegfilgrastim administered in an abbreviated schedule, significantly improved neutrophil recovery after high-dose radiation-induced myelosuppression in rhesus macaques.

Radiation research·2012
Same author

Ischemic preconditioning Nature's own cardioprotective intervention.

Trends in cardiovascular medicine·2011
Same author

Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination?

Archives des maladies du coeur et des vaisseaux·2007
Same author

Cardioprotection: spotlight on PKG.

British journal of pharmacology·2007

Cardiac preconditioning protects the heart against infarction via adenosine and bradykinin receptors. These receptors activate protein kinase C, offering potential therapeutic strategies for heart protection.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pharmacology

Background:

  • The heart exhibits an adaptive response to transient ischemia, known as preconditioning.
  • This phenomenon confers resistance to subsequent, more severe ischemic insults.
  • Preconditioning is conserved across species, including humans.

Purpose of the Study:

  • To review the evidence supporting the protein kinase C (PKC) hypothesis in cardiac preconditioning.
  • To discuss the therapeutic potential of exploiting the preconditioning phenomenon in clinical settings.

Main Methods:

  • Review of existing scientific literature on cardiac preconditioning.
  • Analysis of studies investigating receptor-mediated signaling pathways.
  • Examination of the role of protein kinase C activation.

Related Experiment Videos

Main Results:

  • Adenosine and bradykinin receptor stimulation are key mediators of preconditioning.
  • These receptors likely exert their protective effects through the activation of protein kinase C in cardiomyocytes.
  • Evidence supports the involvement of PKC in the preconditioning cascade.

Conclusions:

  • Cardiac preconditioning is a robust protective mechanism involving specific receptor pathways.
  • Protein kinase C activation is a central component of this protective signaling.
  • Targeting these pathways holds promise for novel clinical interventions against myocardial infarction.